Developer docs
API playgroundTry for free, no card

Search company profiles

Dr. Morepen Limited

Full company profile

uuid0005obw

Namestring
Dr. Morepen Limited
Legal namestring
Dr. Morepen Limited
Company typeenum
Public
Founded yearint
1984
Descriptiontext

Dr. Morepen Limited is an Indian publicly listed healthcare and wellness company (NSE: MOREPENLAB) operating as part of the broader Morepen Laboratories group, founded in 1984 and headquartered at 409 Antriksh Bhawan, 22 K.G. Marg, New Delhi. The company runs a direct-to-consumer e-commerce supplements business through its owned Shopify-based storefront at health.drmorepen.com, offering approximately 115+ SKUs across health supplements (Omega-3, multivitamins), sports nutrition (whey protein, mass gainer, pre-workout, BCAAs), Ayurvedic/herbal products (Shilajit, Testo Boost, Gokshura), probiotics (Intebact), sexual wellness (Exygra spray, condoms), bone and cognitive health, and functional beverages (Cove protein RTD drinks). It targets individual health-conscious consumers, fitness enthusiasts, and women's wellness segments in India, with product pricing from ₹279 to ₹10,500, MRP discounts of 20-50%, bundle deals (Buy 3 @ ₹999, Buy 4 @ ₹1,449, Buy 5 @ ₹1,599), COD, and free shipping to reduce purchase friction.

The company earns revenue primarily through one-time D2C product sales on its owned storefront, supplemented by bundle and B2G1 promotions. Its go-to-market leverages organic social (X, Facebook, Instagram, YouTube), email marketing, content marketing via a health blog, and SEO, with paid and operational integrations including Shiprocket (logistics), UPI/Google Pay/PhonePe (payments), WhatsApp (support), and SearchTap (site search). In 2026 the company deployed Agentic AI customer support bots built on LangChain and ChromaDB via Appinventiv, automating conversational support on the storefront. A flagship partnership with VIT Bhopal University (announced June 2026) extends the model beyond pure retail into on-campus integrated health services (consultations, diagnostics, pharmacy, emergency care, wellness programs) for 17,000+ students and faculty, positioning the company to build a nationwide university, school, and corporate-campus health-centre network. Recent product launches include the Cove functional beverage line (November 2024) and a nutraceutical weight-loss and diabetes-management range (April 2025) targeting the projected ₹10,000+ crore Indian market as alternatives to pharmaceutical GLP-1 drugs.

Short descriptiontext

Dr. Morepen Limited is an Indian publicly listed (NSE: MOREPENLAB) healthcare and wellness company selling ~115+ D2C supplements, sports nutrition, Ayurvedic, and sexual wellness products through its Shopify-based storefront health.drmorepen.com, and expanding into on-campus integrated health services via a partnership-led network starting with VIT Bhopal University.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersNew Delhi, India
HQ citystring
New Delhi
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
health supplements, sports nutrition, nutraceutical products, wellness supplements, pharmaceutical manufacturing
Industry5 codes
1Health Food & Supplement Stores
CodeCRAHAEACPrimaryYes
2Weight Management & Metabolic Supplements
CodeCRADAGAGPrimaryNo
3Probiotics & Digestive Health Supplements
CodeCRADAGAFPrimaryNo
4Online Specialty Grocery (Organic/Health/Ethnic/Gourmet)
CodeCRAHAIAEPrimaryNo
5Specialty Food & Beverage Delivery (organic, gourmet, dietary)
CodeCRAFAFAGPrimaryNo
NAICS code1 code
  • Food (Health) Supplement Retailers456191
SIC code1 code
  • Food And Kindred Products2000
Product category
Health Supplements
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Direct-to-Consumer Health Supplements
TypeOne Time License
Description

E-commerce retail of health supplements, vitamins, sports nutrition, and wellness products directly to consumers through owned online storefront. Revenue generated from one-time product purchases with optional subscription/bundle models.

health.drmorepen.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Marketing or Sales, Technology or R&D, Personnel, Infrastructure
Pricing details2 tiers
1Individual health supplement products with tiered pricing
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products like Omega-3 1250mg Triple Strength at ₹712 (27% off MRP ₹975), Fat Burner at ₹598 (32% off MRP ₹879), Multivitamin Men at ₹499 (42% off MRP ₹875), Mass Gainer at ₹1,199 (20% off MRP ₹1,499), Shilajit Resin from ₹750 (50% off MRP ₹1,499)

health.drmorepen.com
2Bundle deals for multiple products
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Buy 3 @ ₹999, Buy 4 @ ₹1,449, Buy 5 @ ₹1,599 - offering discounted per-unit pricing for bulk purchases

health.drmorepen.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Dr. Morepen Limited manufactures and sells a diversified portfolio of consumer healthcare and wellness products including omega-3/fish oil supplements, multivitamins, weight management products (Fat Burner, Apple Cider Vinegar), sports nutrition (Mass Gainer, Whey Protein, Pre-Workout, BCAAs), Ayurvedic supplements (Shilajit, Testo Boost, Gokshura), probiotics, sexual wellness items, and ready-to-drink beverages. The company retails these primarily through its own direct-to-consumer e-commerce storefront (health.drmorepen.com) and is expanding on-campus health centre services at educational institutions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Products rated 4.0-4.97 out of 5 stars based on customer reviews (e.g., Omega-3: 4.92/5 based on 1106 reviews, Exygra Spray: 4.97/5 based on 1086 reviews)
Product overview1 text field

Dr. Morepen Limited operates a diversified consumer healthcare and wellness business with a broad portfolio of health supplements, sports nutrition products, personal care items, and sexual wellness products. The product line is organized across several core categories: (1) Omega-3 and fish oil supplements including triple-strength and standard formulations, (2) Weight management products including Fat Burner and Apple Cider Vinegar, (3) Multivitamins for men and women with herbal blends, (4) Sports nutrition including mass gainers, whey protein, pre-workout, and amino acid supplements, (5) Ayurvedic and herbal supplements including Shilajit (resin and capsules), Testo Boost, and Gokshura, (6) Probiotic digestive health products under the Intebact brand, (7) Sexual wellness products including Delay Exygra Spray and FEEL IT Condoms, and (8) Specialty supplements for bone health (Calcium+), cognitive function (Memory Booster), and collagen. The company sells through its e-commerce platform health.drmorepen.com with bundled combo offerings and promotional B2G1 deals. Recent additions include the Cove ready-to-drink protein line and gummy supplement formats.

Product and service1 record
1Omega-3 1250mg Deep Sea Fish Oil Triple Strength
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-06-01
Description

Dr. Morepen partnered with VIT Bhopal University to establish a fully integrated Dr. Morepen Health Centre within the university campus in Madhya Pradesh, India. The health centre provides comprehensive medical consultations, diagnostics, pharmacy services, emergency care support, and wellness programs for over 17,000 students, faculty, and staff. This partnership marks the first step in Dr. Morepen's plan to build a nationwide network of health centres across universities, schools, and corporate campuses throughout India.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

India-based herbal and organic supplements brand (Tulsi, Ashwagandha, functional wellness). Comparable on the herbal/Ayurvedic supplement positioning and D2C/retail hybrid; smaller scale and narrower line than Dr. Morepen.

TypeBroad incumbent
Description

India's largest online multi-brand supplements and sports-nutrition retailer. Overlaps with Dr. Morepen across every supplement vertical; broad-incumbent because it carries competitors' brands and is a channel rather than a single-label manufacturer.

TypeDirect peer
Description

Largest Indian herbal/Ayurvedic supplements and personal-care brand. Highly comparable to Dr. Morepen because both sell herbal and modern wellness SKUs (Shilajit, Ashwagandha, multivitamins) through Indian retail and D2C channels targeting health-conscious consumers.

TypeDirect peer
Description

Leading Indian Ayurveda FMCG brand with an extensive supplements, health-food and personal-care portfolio sold via retail and online. Directly comparable product overlap (herbal supplements, Ayurvedic wellness) and overlapping target consumer in Tier-2/3 India.

TypeDirect peer
Description

India-focused D2C sports-nutrition and supplement brand selling whey protein, mass gainers, pre-workout, and vitamins — near-identical SKU overlap to Dr. Morepen's sports-nutrition line and comparable D2C + marketplace GTM.

TypeEmerging player
Description

India health-services startup building diagnostic and primary-care networks — relevant comp on the university/campus and corporate health-centre expansion thesis that Dr. Morepen is pursuing with VIT Bhopal, not on the supplement product.

TypeBroad incumbent
Description

Large listed Indian FMCG with a significant Ayurveda/health-supplements portfolio (Dabur Honey, Chyawanprash, Ashwagandha). Broad-incumbent because it competes in the same categories but as part of a much larger foods-personal-care portfolio.

TypeEmerging player
Description

Indian D2C wellness and beauty-nutrition brand offering gummy and effervescent vitamins, weight-management and beauty supplements. Comparable on D2C-native GTM and functional-wellness positioning; smaller scale.

TypeBroad incumbent
Description

Global specialty supplements retailer with an India presence. Comparable SKU mix (vitamins, sports nutrition, herbal blends) but operates as a broad multi-brand retailer rather than a single-label brand.

TypeDirect peer
Description

Indian D2C daily-health supplement brand with a comparable positioning around multivitamins, Omega-3, and condition-specific wellness SKUs sold online. Closest direct peer in the modern-D2C supplement category rather than legacy Ayurveda.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Dr. Morepen Limited

Health Supplementshealth.drmorepen.com

Dr. Morepen Limited is an Indian publicly listed (NSE: MOREPENLAB) healthcare and wellness company selling ~115+ D2C supplements, sports nutrition, Ayurvedic, and sexual wellness products through its Shopify-based storefront health.drmorepen.com, and expanding into on-campus integrated health services via a partnership-led network starting with VIT Bhopal University.

What Dr. Morepen Limited does

Dr. Morepen Limited is an Indian publicly listed healthcare and wellness company (NSE: MOREPENLAB) operating as part of the broader Morepen Laboratories group, founded in 1984 and headquartered at 409 Antriksh Bhawan, 22 K.G. Marg, New Delhi. The company runs a direct-to-consumer e-commerce supplements business through its owned Shopify-based storefront at health.drmorepen.com, offering approximately 115+ SKUs across health supplements (Omega-3, multivitamins), sports nutrition (whey protein, mass gainer, pre-workout, BCAAs), Ayurvedic/herbal products (Shilajit, Testo Boost, Gokshura), probiotics (Intebact), sexual wellness (Exygra spray, condoms), bone and cognitive health, and functional beverages (Cove protein RTD drinks). It targets individual health-conscious consumers, fitness enthusiasts, and women's wellness segments in India, with product pricing from ₹279 to ₹10,500, MRP discounts of 20-50%, bundle deals (Buy 3 @ ₹999, Buy 4 @ ₹1,449, Buy 5 @ ₹1,599), COD, and free shipping to reduce purchase friction.

The company earns revenue primarily through one-time D2C product sales on its owned storefront, supplemented by bundle and B2G1 promotions. Its go-to-market leverages organic social (X, Facebook, Instagram, YouTube), email marketing, content marketing via a health blog, and SEO, with paid and operational integrations including Shiprocket (logistics), UPI/Google Pay/PhonePe (payments), WhatsApp (support), and SearchTap (site search). In 2026 the company deployed Agentic AI customer support bots built on LangChain and ChromaDB via Appinventiv, automating conversational support on the storefront. A flagship partnership with VIT Bhopal University (announced June 2026) extends the model beyond pure retail into on-campus integrated health services (consultations, diagnostics, pharmacy, emergency care, wellness programs) for 17,000+ students and faculty, positioning the company to build a nationwide university, school, and corporate-campus health-centre network. Recent product launches include the Cove functional beverage line (November 2024) and a nutraceutical weight-loss and diabetes-management range (April 2025) targeting the projected ₹10,000+ crore Indian market as alternatives to pharmaceutical GLP-1 drugs.

Dr. Morepen Limited firmographics

Firmographics
Name
Dr. Morepen Limited
Legal name
Dr. Morepen Limited
Website
https://health.drmorepen.com/
Company type
Public
Founded year
1984
Operating status
Operating
Headcount range
251–500 employees
Short description
Dr. Morepen Limited is an Indian publicly listed (NSE: MOREPENLAB) healthcare and wellness company selling ~115+ D2C supplements, sports nutrition, Ayurvedic, and sexual wellness products through its Shopify-based storefront health.drmorepen.com, and expanding into on-campus integrated health services via a partnership-led network starting with VIT Bhopal University.
Ownership category
akta.pro rank

Dr. Morepen Limited industry classification

Industry
Product category
Health Supplements
NAICS
Food (Health) Supplement Retailers (456191)
SIC
Food And Kindred Products (2000)
akta.pro primary industry
Health Food & Supplement Stores (CRAHAEAC)
akta.pro secondary industries
Weight Management & Metabolic Supplements (CRADAGAG), Probiotics & Digestive Health Supplements (CRADAGAF), Online Specialty Grocery (Organic/Health/Ethnic/Gourmet) (CRAHAIAE), Specialty Food & Beverage Delivery (organic, gourmet, dietary) (CRAFAFAG)

Keywords

  • Health supplements
  • Sports nutrition
  • Nutraceutical products
  • Wellness supplements
  • Pharmaceutical manufacturing

Where Dr. Morepen Limited is headquartered

Location

Headquarters

HQ city
New Delhi
HQ country
India
HQ region
Asia

Offices1 record

Markets served

Dr. Morepen Limited business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Marketing or Sales, Technology or R&D, Personnel, Infrastructure

Revenue model

  1. Direct-to-Consumer Health Supplements: E-commerce retail of health supplements, vitamins, sports nutrition, and wellness products directly to consumers through owned online storefront. Revenue generated from one-time product purchases with optional subscription/bundle models.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goIndividual health supplement products with tiered pricing
Unit PricingPay-as-you-goBundle deals for multiple products

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Dr. Morepen Limited product offering

Product offering

Core offering

Dr. Morepen Limited manufactures and sells a diversified portfolio of consumer healthcare and wellness products including omega-3/fish oil supplements, multivitamins, weight management products (Fat Burner, Apple Cider Vinegar), sports nutrition (Mass Gainer, Whey Protein, Pre-Workout, BCAAs), Ayurvedic supplements (Shilajit, Testo Boost, Gokshura), probiotics, sexual wellness items, and ready-to-drink beverages. The company retails these primarily through its own direct-to-consumer e-commerce storefront (health.drmorepen.com) and is expanding on-campus health centre services at educational institutions.

Product overview

Dr. Morepen Limited operates a diversified consumer healthcare and wellness business with a broad portfolio of health supplements, sports nutrition products, personal care items, and sexual wellness products. The product line is organized across several core categories: (1) Omega-3 and fish oil supplements including triple-strength and standard formulations, (2) Weight management products including Fat Burner and Apple Cider Vinegar, (3) Multivitamins for men and women with herbal blends, (4) Sports nutrition including mass gainers, whey protein, pre-workout, and amino acid supplements, (5) Ayurvedic and herbal supplements including Shilajit (resin and capsules), Testo Boost, and Gokshura, (6) Probiotic digestive health products under the Intebact brand, (7) Sexual wellness products including Delay Exygra Spray and FEEL IT Condoms, and (8) Specialty supplements for bone health (Calcium+), cognitive function (Memory Booster), and collagen. The company sells through its e-commerce platform health.drmorepen.com with bundled combo offerings and promotional B2G1 deals. Recent additions include the Cove ready-to-drink protein line and gummy supplement formats.

Differentiator

Problem solved

Functional benefit

Products and services

  • Omega-3 1250mg Deep Sea Fish Oil Triple Strength

Quantifiable outcome

  • Products rated 4.0-4.97 out of 5 stars based on customer reviews (e.g., Omega-3: 4.92/5 based on 1106 reviews, Exygra Spray: 4.97/5 based on 1086 reviews)

Companies that use Dr. Morepen Limited

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Dr. Morepen Limited technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

AI capability2 records

Feature1 record

Dr. Morepen Limited partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • VIT Bhopal UniversityflagshipStrategic or Co-development Partner · 1 June 2026Dr. Morepen partnered with VIT Bhopal University to establish a fully integrated Dr. Morepen Health Centre within the university campus in Madhya Pradesh, India. The health centre provides comprehensive medical consultations, diagnostics, pharmacy services, emergency care support, and wellness programs for over 17,000 students, faculty, and staff. This partnership marks the first step in Dr. Morepen's plan to build a nationwide network of health centres across universities, schools, and corporate campuses throughout India.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Dr. Morepen Limited competitors and assessment

Company assessment

Emerging players

  • Organic India: India-based herbal and organic supplements brand (Tulsi, Ashwagandha, functional wellness). Comparable on the herbal/Ayurvedic supplement positioning and D2C/retail hybrid; smaller scale and narrower line than Dr. Morepen.
  • Ayu Health (Ayu Sciences): India health-services startup building diagnostic and primary-care networks — relevant comp on the university/campus and corporate health-centre expansion thesis that Dr. Morepen is pursuing with VIT Bhopal, not on the supplement product.
  • Plix (The Plix Co.): Indian D2C wellness and beauty-nutrition brand offering gummy and effervescent vitamins, weight-management and beauty supplements. Comparable on D2C-native GTM and functional-wellness positioning; smaller scale.

Broad incumbents

  • HealthKart: India's largest online multi-brand supplements and sports-nutrition retailer. Overlaps with Dr. Morepen across every supplement vertical; broad-incumbent because it carries competitors' brands and is a channel rather than a single-label manufacturer.
  • Dabur India: Large listed Indian FMCG with a significant Ayurveda/health-supplements portfolio (Dabur Honey, Chyawanprash, Ashwagandha). Broad-incumbent because it competes in the same categories but as part of a much larger foods-personal-care portfolio.
  • GNC (General Nutrition Center): Global specialty supplements retailer with an India presence. Comparable SKU mix (vitamins, sports nutrition, herbal blends) but operates as a broad multi-brand retailer rather than a single-label brand.

Direct peers

  • Himalaya Wellness: Largest Indian herbal/Ayurvedic supplements and personal-care brand. Highly comparable to Dr. Morepen because both sell herbal and modern wellness SKUs (Shilajit, Ashwagandha, multivitamins) through Indian retail and D2C channels targeting health-conscious consumers.
  • Patanjali Ayurved: Leading Indian Ayurveda FMCG brand with an extensive supplements, health-food and personal-care portfolio sold via retail and online. Directly comparable product overlap (herbal supplements, Ayurvedic wellness) and overlapping target consumer in Tier-2/3 India.
  • MuscleBlaze (Bright Lifecare): India-focused D2C sports-nutrition and supplement brand selling whey protein, mass gainers, pre-workout, and vitamins — near-identical SKU overlap to Dr. Morepen's sports-nutrition line and comparable D2C + marketplace GTM.
  • TrueBasics (by Fullife Healthcare): Indian D2C daily-health supplement brand with a comparable positioning around multivitamins, Omega-3, and condition-specific wellness SKUs sold online. Closest direct peer in the modern-D2C supplement category rather than legacy Ayurveda.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Dr. Morepen Limited social profiles

Digital presence

Dr. Morepen Limited financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Dr. Morepen Limited leadership team

Management profile

Number of profiles

Profiles2 records

Dr. Morepen Limited funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Dr. Morepen Limited M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dr. Morepen Limited

What does Dr. Morepen Limited do?

Dr. Morepen Limited manufactures and sells a diversified portfolio of consumer healthcare and wellness products including omega-3/fish oil supplements, multivitamins, weight management products (Fat Burner, Apple Cider Vinegar), sports nutrition (Mass Gainer, Whey Protein, Pre-Workout, BCAAs), Ayurvedic supplements (Shilajit, Testo Boost, Gokshura), probiotics, sexual wellness items, and ready-to-drink beverages. The company retails these primarily through its own direct-to-consumer e-commerce storefront (health.drmorepen.com) and is expanding on-campus health centre services at educational institutions.

Is Dr. Morepen Limited a public or private company?

Dr. Morepen Limited is a public company. It is classified as public and is currently operating.

When was Dr. Morepen Limited founded?

Dr. Morepen Limited was founded in 1984. It employs 251 to 500 people.

Where is Dr. Morepen Limited based?

Dr. Morepen Limited is headquartered in New Delhi, India, in the Asia region.

How does Dr. Morepen Limited make money?

One revenue line is on record: direct-to-Consumer Health Supplements.

Who are Dr. Morepen Limited's main competitors?

Emerging players on record are Organic India, Ayu Health (Ayu Sciences) and Plix (The Plix Co.). Broad incumbents are HealthKart, Dabur India and GNC (General Nutrition Center). Direct peers are Himalaya Wellness, Patanjali Ayurved, MuscleBlaze (Bright Lifecare) and TrueBasics (by Fullife Healthcare).

Does Dr. Morepen Limited have an API?

No public API is recorded for Dr. Morepen Limited.

What industry is Dr. Morepen Limited in?

Dr. Morepen Limited's product category is Health Supplements. Its primary akta.pro industry code is CRAHAEAC, Health Food & Supplement Stores, with a secondary code of CRADAGAG, Weight Management & Metabolic Supplements. Its NAICS code is 456191 and its SIC code is 2000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business StandardMorepen Laboratories files its first US ANDA for sitagliptin tabletsMorepen Laboratories submitted its first US ANDA for sitagliptin tablets in 25, 50, and 100 mg strengths on September 25, 2026. The submission expands its CDMO capabilities and targets approval within 24-36 months, with the relevant patent expiring in November 2026.BusinessLineMorepen files first US drug application, eyes generic diabetes marketMorepen Laboratories filed its first US drug application for Sitagliptin tablets on September 25, 2026, targeting the generic diabetes market. The branded drug Januvia generated $1.604 billion in global sales in 2025, and the patent expires in November 2026. Morepen estimates a 24-36-month timeline to approval and commercial supply.Business StandardMorepen Laboratories submits first ANDA to USFDA for Sitagliptin TabletsMorepen Laboratories submitted its first ANDA to the FDA for Sitagliptin tablets in 25, 50, and 100 mg strengths. The submission extends its CDMO expertise into finished dosage development and regulatory filing. The company estimates 24-36 months to progress toward approval and commercial supply, subject to FDA review and other requirements.ScanXMorepen Laboratories files first US ANDA for Sitagliptin TabletsMorepen Laboratories submitted its first US ANDA for Sitagliptin Tablets USP in 25, 50, and 100 mg strengths on September 25, 2026. The innovator Januvia recorded $1.604 billion in global sales in 2025, and the patent expires in November 2026. Morepen estimates a 24-36 month timeline to potential approval.Fortune IndiaMorepen Laboratories shares jump 5% after first US ANDA filing for diabetes drug; zoom 267% in 6 monthsMorepen Laboratories shares rose nearly 5% after it submitted its first US FDA ANDA for Sitagliptin tablets for type 2 diabetes. The filing marks expansion into finished dosage development, and the stock has gained 267% over six months. The company estimates 24–36 months to progress toward approval and commercial supply.Business StandardMorepen Labs Share Price: Morepen Labs rises 7% to 52-week high; what moved this multibagger stock?Morepen Laboratories shares rose 7% to a 52-week high after completing its first phase of manufacturing capacity expansion ahead of schedule. The company's installed reactor capacity increased from 535 KL to 614 KL, and Q1 FY27 profit after tax jumped 394% to ₹56.35 crore, with revenue up 34% to ₹575.31 crore.Business News TodayPrice Action: Molbio Diagnostics falls 2% despite profitable in Q2; Jayaswal Neco, Morepen Laboratories shares gainMolbio Diagnostics shares fell 2% despite reporting a consolidated profit of ₹58.7 crore and revenue of ₹408.4 crore, up nearly four-fold year-on-year. Jayaswal Neco gained 2% after clarifying no direct transactions with related entities, while Morepen Laboratories rose 3% on completing its first manufacturing expansion phase.Business StandardMorepen Laboratories successfully completes phase 1 of capacity expansionMorepen Laboratories completed phase 1 of its manufacturing capacity expansion ahead of schedule. Installed reactor capacity for API and CDMO rose from 535 KL to 614 KL, strengthening readiness for commercial CDMO scale-up and supporting existing API business and future customer programs.MintBreakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today —4 September 2026Sumeet Bagadia recommends five stocks to buy on September 4: Kirloskar Oil Engines, Morepen Laboratories, MSTC, IOL Chemicals, and Vishnu Chemicals. Each has a buy price, target, and stop-loss, with targets ranging from ₹127 to ₹2460. The recommendations follow a market decline on September 3.Business TodayPharma API, CRAMS firms see sharp profit acceleration in Q1 FY27Pharma API and CRAMS firms saw median profit after tax growth of 47.1% in June 2026, up from 8% in March, while revenue growth was 18.8%. The acceleration was driven by CDMO projects, capacity additions, and new product launches, with Morepen Laboratories and Aarti Pharmalabs cited as examples.